Notice Pursuant to the National Cooperative Research and Production Act of 1993-Standards-Based Interoperable Guideline System Joint Venture

---
identifier: "/us/fr/02-1592"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Notice Pursuant to the National Cooperative Research and Production Act of 1993-Standards-Based Interoperable Guideline System Joint Venture"
title_number: 0
title_name: "Federal Register"
section_number: "02-1592"
section_name: "Notice Pursuant to the National Cooperative Research and Production Act of 1993-Standards-Based Interoperable Guideline System Joint Venture"
positive_law: false
currency: "2002-01-23"
last_updated: "2002-01-23"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Justice Department"
document_number: "02-1592"
document_type: "notice"
publication_date: "2002-01-23"
agencies:
  - "Justice Department"
  - "Antitrust Division"
fr_citation: "67 FR 3236"
fr_volume: 67
---


#  Notice Pursuant to the National Cooperative Research and Production Act of 1993—Standards-Based Interoperable Guideline System Joint Venture

Notice is hereby given that, on November 26, 2001, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 *et seq.* (“the Act”), IDX Systems Corporation has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the identities of the parties and (2) the nature and objectives of the venture. The notifications were filed for the purpose of invoking the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Pursuant to section 6(b) of the Act, the identities of the parties are IDX Systems Corp., Seattle, WA; Apelon, Inc., Ridgefield, CT; Stanford University, Stanford, CA; Mayo Clinic Rochester, Rochester, MN; IHC Health Services, Inc., Salt Lake City, UT; and Board of Regents, University of Nebraska, University of Nebraska Medical Center, Omaha, NE. The nature and objectives of the venture are the development of healthcare software consisting of a computable format for representing clinical interoperable guidelines, a tool for authoring and editing these guidelines, and software which maps and integrate guideline content into clinical information systems.

Constance K. Robinson,

Director of Operations, Antitrust Division.